Journal profile · Pharmacology & Pharmacy
Biochemical Pharmacology
ISSN 0006-2952 · eISSN 1873-2968 · Elsevier Inc. · UNITED STATES · Semimonthly · Founded 1958
Biochemical Pharmacology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 6.52; hybrid open access; APC about USD 3,590; median 78 days to acceptance (94 articles, last 24 months); community-reported acceptance: about 50%; 785 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Biochemical Pharmacology is published by Elsevier Inc. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms and Receptor Mechanisms and Signaling, together about 27.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Browse through a wide range of high-quality academic journals offered by Elsevier, including open access options, to enrich your research journey.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics11.1%
- Drug Transport and Resistance MechanismsMedicine9.2%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology7.7%
- Neuroscience and Neuropharmacology ResearchNeuroscience7.1%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology4.7%
- Eicosanoids and Hypertension PharmacologyBiochemistry, Genetics and Molecular Biology4.4%
- Metabolism and Genetic DisordersBiochemistry, Genetics and Molecular Biology4%
- Nitric Oxide and Endothelin EffectsMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.52LetPub ·
- CiteScore 2026-06
- 9.3LetPub ·
- SJR 2026-06
- 1.69LetPub ·
- SNIP 2026-06
- 1.31LetPub ·
- h-index
- 181LetPub ·
- h-index
- 294OpenAlex ·
- i10-index
- 22,476OpenAlex ·
- 2-year mean citedness
- 4.9OpenAlex ·
- Self-citation rate
- 1.5%LetPub ·
- Share of gold OA articles
- 22.66%LetPub ·
Volume
- Articles per year
- 736LetPub ·
Articles by year OpenAlex count · 33,483 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 743 | 171 | 547 |
| 2025 | 785 | 212 | 3,176 |
| 2024 | 603 | 231 | 6,728 |
| 2023 | 505 | 166 | 9,679 |
| 2022 | 403 | 130 | 10,556 |
| 2021 | 412 | 154 | 12,712 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
78 daysMedian, submission to acceptance · P25–P75 55 days – 108 days
- Acceptance to online
- median 2 days (94 articles)
- Submission to online
- median 81 days
- Sample
- 94 articles with submission and acceptance dates (1,716 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,590 / EUR 3,360 / GBP 2,870 / JPY 445,270 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Elsevier Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Semimonthly
- Founded
- 1958
- ISSN
- 0006-2952
- Electronic ISSN
- 1873-2968
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Biochemical Pharmacology
What CAS zone is Biochemical Pharmacology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Biochemical Pharmacology is in Zone 2 of Medicine, and in Zone 2 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Biochemical Pharmacology?
The latest impact factor listed by LetPub is 6.52; CiteScore 9.3, h-index 294.
How long does peer review take at Biochemical Pharmacology?
Based on the dates recorded on 94 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 78 days (interquartile range 55–108 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Biochemical Pharmacology?
According to LetPub and DOAJ records, Biochemical Pharmacology is indexed in SCIE and Scopus.
Is Biochemical Pharmacology open access, and what is the APC?
Biochemical Pharmacology is a hybrid journal. For open-access publication: APC about USD 3,590.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .